Mylan’s stock has fallen by more than three-fourths in the last 4 years. The company announced a merger with UpJohn this year, and the market received it well. Investors need to make decisions around ...

Their merger isn't official yet, but a new logo is ready to go. Mylan and Pfizer's Upjohn unit unveiled new branding for the to-be-combined company, dubbed Viatris, on Thursday with a tri-color scheme ...

Finding the perfect name is no easy task for a new company, particularly in the exotic world of biopharma monikers. Mylan and Pfizer's Upjohn, working to close their generics megamerger, believe they ...

The early reaction to the pairing of generic drug maker Mylan Laboratories and Pfizer’s generics unit, Upjohn — officially announced Monday — is that it’s great for Mylan but maybe not so amazing for ...

Mylan NV and Pfizer on Tuesday said the name of the new company to be formed after the merger of Mylan and Pfizer division Upjohn will be Viatris. A note issued by Mylan says the name is derived from ...

Mylan will sell rights and assets related to seven generic drugs to Alvogen Group in order to settle a complaint by the U.S. Federal Trade Commission (FTC) related to the company’s proposed $27 ...

PITTSBURGH (KDKA/AP) -- Pfizer is buying Mylan in an all-stock deal and combining the $10 billion generic pharmaceutical company with its own off-patent branded and generic business. The Pfizer ...